M46.87 classifies inflammatory spondylopathies of the lumbosacral region that are specified but do not fit any named inflammatory spondylopathy category — such as ankylosing spondylitis (M45) or sacroiliitis (M46.1) — when the pathology involves the L5-S1 junction and surrounding structures.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 12
- Region
- Spine
Documentation tips
What should appear in the chart to support M46.87.
Source · Editorial brief grounded in 5 cited references ↓
- Name the specific inflammatory condition — 'undifferentiated spondyloarthropathy, lumbosacral region' or 'reactive spondylitis at L5-S1' — rather than a generic 'low back pain with inflammation' to justify M46.87 over a symptom code.
- Confirm the region explicitly: document 'lumbosacral' or reference L5-S1 involvement by level. 'Lumbar spine' alone maps to M46.86, not M46.87.
- Record imaging findings that support an inflammatory etiology — MRI bone marrow edema, erosions at the L5-S1 endplates, or gadolinium enhancement — to substantiate the inflammatory spondylopathy classification.
- Document that more specific inflammatory spondylopathy categories (ankylosing spondylitis, sacroiliitis NEC, spinal osteomyelitis) were considered and do not fit the clinical picture, establishing why 'other specified' is the correct level of specificity.
- Note relevant lab markers (elevated CRP, ESR, HLA-B27 status) in the assessment — payers use this to validate inflammatory vs. mechanical back conditions when reviewing medical necessity for advanced imaging or biologics.
Related CPT procedures
Procedure codes commonly billed with M46.87. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M46.87 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Assigning M46.87 when M46.86 (lumbar region) is correct — the lumbosacral code requires documented involvement at the L5-S1 junction, not just general lower lumbar pathology.
- Using M46.87 for ankylosing spondylitis at the lumbosacral level — ankylosing spondylitis has its own category (M45.x) and must be coded there, not as 'other specified.'
- Defaulting to M46.87 when the spondylopathy type is genuinely unknown — unspecified inflammatory spondylopathy at the lumbosacral region belongs under M46.97, not M46.87, which requires the type to be identified even if not a named ICD category.
- Confusing M46.87 with M46.1 (sacroiliitis NEC) when the provider documents sacroiliac joint inflammation — M46.1 is its own billable code and takes priority when SI joint pathology is the primary finding.
- Pairing M46.87 with a nonspecific low back pain code (M54.5x) on the same claim without a clear hierarchy — M46.87 should be sequenced as the primary diagnosis when an inflammatory spondylopathy is confirmed, with pain codes as secondary if at all.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
Use M46.87 when the clinical record documents an inflammatory process affecting the lumbosacral spine and the condition is identified as a specific entity that still falls outside the named codes in M45–M46.6. Common examples include undifferentiated spondyloarthropathy localized to the lumbosacral region, psoriatic spondylitis documented at the lumbosacral level, or reactive spondylopathy where the provider has specified the inflammatory nature without a more precise category being available.
M46.87 sits within the M46.8x family, which covers 'other specified inflammatory spondylopathies' across all spinal regions. The 7th character in this subgroup encodes the spinal region: M46.86 covers the lumbar region, M46.87 the lumbosacral region, and M46.88 the sacral and sacrococcygeal region. Do not use M46.87 for pure lumbar involvement — that is M46.86. The lumbosacral region code applies specifically when the inflammatory pathology spans or involves the L5-S1 articulation and adjacent segments.
This code does not apply to ankylosing spondylitis (use M45.x), sacroiliitis not elsewhere classified (use M46.1), or infectious discitis/osteomyelitis at the same level (use M46.2x–M46.5x). If the inflammatory spondylopathy affects multiple spinal regions, consider M46.89 (multiple sites). Unspecified inflammatory spondylopathy at the lumbosacral level falls under M46.97, not M46.87 — specificity in the clinical note is what earns the M46.87 code.
Sibling codes
Other billable codes under M46.8 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What is the difference between M46.87 and M46.86?
02Can M46.87 be used for ankylosing spondylitis at the lumbosacral level?
03When should I use M46.97 instead of M46.87?
04Does M46.87 require a 7th character?
05Is M46.87 appropriate for a patient with psoriatic arthritis affecting the lumbosacral spine?
06What CPT procedures are commonly billed with M46.87?
07Will payers accept M46.87 without supporting imaging?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (FY2026, effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M45-M49/M46-/M46.87
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M46.87
- 04cms.govhttps://www.cms.gov/medicare/coding/icd10/downloads/icd10clinicalconceptsorthopedics1.pdf
- 05aaos.orghttps://www.aaos.org/globalassets/quality-and-practice-resources/coding-and-reimbursement/resident-guide/resident-guide_icd10.pdf
Mira AI Scribe
Mira captures the spinal region (lumbosacral / L5-S1), the inflammatory qualifier, the specific condition name as documented by the provider, and any supporting imaging or lab findings from the encounter. This prevents the claim from dropping to M46.97 (unspecified) or M46.80 (site unspecified) — both of which carry higher audit risk and may fail medical necessity review for advanced imaging or injection procedures.
See how Mira captures M46.87 documentation